





























	 A	 series	 of	 new	 cholesterol	 derivatives	 have	 been	 prepared	 via	 Mitsunobu	 reaction.	 Thereaction	was	monitored	by	thin‐layer	chromatography	(TLC)	technique.	All	new	compounds
were	 characterized	 by	 melting	 points,	 elemental	 analysis,	 FT‐IR,	 1H,	 13C	 and	 2D‐NMR
spectroscopy.	 The	 antibacterial	 and	 antifungal	 activity	 of	 these	 derivatives	 was	 also
determined.	The	phase	transitions	of	the	prepared	derivatives	were	measured	with	the	aid	of
differential	 scanning	 calorimetry.	 The	 textures	 of	 the	 mesophases	 have	 been	 determined
with	 a	 hot	 stage	 equipped	 polarizing	 microscope,	 also	 the	 electrical	 conductivity	 of	 the













Steroids	 are	 derivative	 lipids	 [1],	 organic	 materials	
produced	 naturally	 from	 all	 the	 life	 forms	 that	 include	
microorganisms	of	plants	and	animals	[2].	Cholesterol	is	one	of	
the	 most	 important	 steroids	 [3],	 and	 is	 a	 very	 important	
substance	 found	 in	 the	 body	 of	 the	 organism	 enters	 in	 the	
composition	of	the	animal	cell	wall	[4].	
Liquid	 crystals	 are	 mesophases	 between	 a	 crystalline	
phase	 (Solid	phase)	 and	 isotropic	phase	 (Liquid	phase)	 [5,6].	
Historically,	 the	 first	 liquid	 crystalline	 compound	 was	
discovered	 by	 the	 Austrian	 botanist,	 Friedrich	 Reinitzer	 in	
1888	 [7].	 He	 had	 observed	 that	 when	 first	 heating	 of	
cholesteryl	benzoate	showed	not	a	clear	liquid	state,	but	when	
increase	 the	 heating	 produced	 a	 clear	 liquid	 [8].	 Liquid	
crystalline	phases	can	be	classified	into	two	classes:	Lyotropic	
LC	 and	 Thermotropic	 LC	 [9].	 The	 phase	 of	 lyotropic	 LC	
characteristic	 ordering	 depends	 on	 solvent	 [10].	 While	 the	
phase	of	thermotropic	LC	characteristic	ordering	depends	only	
on	 temperature	 [11],	 thermotropic	 LC	 phases	 are:	 nematic,	
smectic,	 and	 cholesteric	 [12].	 Cholesteric	 liquid	 crystals	 have	
many	advanced	technology	applications	[13]	like	liquid	crystal	












The	 melting	 point	 was	 determined	 on	 a	 digital	 melting	




Elemental	 Analyzer	 (Vario,	 Shimadzu,	 Japan).	 The	 FT‐IR	
spectra	were	 recorded	 in	 KBr	 pellets	 using	 Biotech,	 CO.	 Ltd.	
UK,	FT‐IR	spectrometer.	Polarized	optical	microscope	analysis	
data	 were	 collected	 on	 a	 LEICA	 DM	 2500P.	 Differential	
scanning	 calorimetry	 analysis	 data	 were	 collected	 on	 a	
























































Carboxylic	 acids	 (9‐16)	 (2.5	 mmol),	 triphenylphosphine	
(Ph3P)	(2.5	mmol,	0.65	g)	and	diethylazodicarboxylate	(DEAD)	
(2.5	mmol,	0.43	g)	were	added	to	a	solution	of	cholesterol	(2.5	
mmol,	 1	 g)	 in	 dry	 pyridine	 (15	 mL)	 and	 the	 mixture	 was	
stirred	at	40	°C	 for	72	hours.	The	reaction	was	monitored	by	






1H‐cyclopenta[a]phenanthren‐3‐yl	 3,	 4‐dihydroxybenzoate	 (1):	
From	 2,4‐dihydroxy	 benzoic	 acid	 (9).	 Color:	 Yellow.	 Yield:	
92%.	M.p.:133‐135	 °C.	 FT‐IR	 (KBr,	 ν,	 cm‐1):	 1050‐1250	 (C‐O,	
ester),	1400	(C‐O,	phenol),	1600	(C=C,	aliphatic	and	aromatic),	
1750	 (C=O,	 ester),	 3050	 (=C‐H,	 aliphatic),	 3060	 (C‐H,	
aromatic),	3400	(O‐H,	phenol).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	
ppm):	 0.69	 (s,	 3H,	H18),	 0.97	 (d,	 3H,	H21),	 1.04‐1.05	 (d,	 6H,	
H26	+ H27),	1.11	(s,	3H,	H19),	1.131	(m,	1H,	H9),	1.138	(m,	2H,	
H1B),	 1.18‐1.20	 (m,	 4H,	 H14	 +	 H15B	 +	 H17),	 1.208	 (m,	 2H,	
H24),	 1.209	 (m,	 2H,	 H22),	 1.21	 (m,	 2H,	 H23),	 1.411	 (m,	 2H,	
H2B),	1.43	(m,	2H,	H20	+	H8),	1.44	(m,	2H,	H12B),	1.45	(m,	2H,	
H16B),	 1.52	 (m,	 2H,	 H11B),	 1.53	 (m,	 2H,	 H7B),	 1.57	 (m,	 1H,	
H25),	2.16	(m,	2H,	H4),	2.19	(m,	1H,	H3),	4.25	(s,	1H,	OH),	5.24	
(br,	s,	1H,	OH),	5.29	(t,	1H,	H6),	6.58	(d,	1H,	5’Harom),	7.40	(s,	
1H,	 2’Harom),	 7.43	 (d,	 1H,	 6’Harom).	 13C	 NMR	 (100	 MHZ,	
DMSO‐d6,	 δ,	ppm):	14.8	 (Me‐18),	19.2	 (Me‐21),	19.5	 (Me‐19),	
21.1	 (C‐11),	 23.0	 (C‐23),	23.1	 (C‐26+	C‐27),	23.8	 (C‐16),	24.4	




1’),	 142.1	 (C‐5),	 144.7	 (3’COH),	 147.0	 (4’COH),	 164.8	 (CO2).	
Anal.	calcd.	for	C34H50O4:	C,	78.12;	H,	9.64.	Found:	C,	77.89;	H,	
9.56%.	
(2S)‐((10R,	 13R,	 17R)‐10,	 13‐dimethyl‐17‐((R)‐6‐methyl	
heptan‐2‐yl)‐2,	3,	4,	7,	8,	9,	10,	11,	12,	13,	14,	15,	16,	17‐tetra	
decahydro‐1H‐cyclopenta[a]phenanthren‐3‐yl)	 2‐(6‐methoxy	
naphthalen‐2‐yl)propanoate	 (2):	 From	 (S)‐2‐(6‐methoxy	
naphthalen‐2‐yl)propanoic	 acid	 (10)	 (0.57	 g).	 Color:	 Yellow.	
Yield:	89%.	M.p.:	113‐115	°C.	FT‐IR	(KBr,	ν,	cm‐1):	1050‐1200	
(C‐O,	 ester),	 1356	 (C‐O,	 phenol),	 1531	 (C=C,	 aliphatic	 and	
aromatic),	1603	(C=O,	ester),	3051	(=C‐H,	aliphatic),	3060	(C‐
H,	aromatic).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	0.96	(s,	3H,	







1”H),	 5.279	 (t,	 1H,	 H6),	 7.28	 (d,	 1H,	 7’	 Harom),	 7.30	 (s,	 1H,	





19),	 21.3	 (C‐11),	 23.1	 (C‐23),	 23.2	 (C‐26+C‐27),	 23.9	 (C‐16),	
24.2	 (C‐15),	 27.9	 (C‐14),	 28.0	 (C‐25),	 32.0	 (C‐2),	 32.1	 (C‐8),	
32.2	 (C‐7),	 39.4	 (C‐20+C‐22),	 39.6	 (C‐10),	 40.01	 (C‐1),	 40.02	
(C‐9),	40.20	(OMe),	40.28	(C‐14),	40.29	(C‐17),	40.30	(C‐12	),	
40.35	(C‐4),	40.41	(C‐1”),	40.71	(C‐24),	40.75	(C‐13),	40.79	(C‐





3,	 4,	 7,	 8,	 9,	 10,	 11,	 12,	 13,	 14,	 15,	 16,	 17‐tetradecahydro‐1H‐
cyclopenta[a]phenanthren‐3‐yl	 2‐aminobenzoate	 (3):	 From	 2‐
aminobenzoicacid	 (11)	 (0.34	 mg).	 Color:	 White.	 Yield:	 89%.	
M.p.:	108‐110	°C.	FT‐IR	(KBr,	ν,	cm‐1):	1019‐1209	(C‐O,	ester),	
1354	 (C‐N,	 aromatic),	 1516	 (N‐H,	 b,	 aromatic	 amine),	 1609	
(C=C,	aliphatic	and	aromatic),	1754	 (C=O,	ester),	3035	(=C‐H,	
aliphatic),	 3074	 (C‐H,	 aromatic),	 331	 3375- 	 (N‐H,	 s,	 aromatic	
amine).	 1H	 NMR	 (400	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 0.73	 (s,	 3H,	
H18),	 1.04	 (d,	 3H,	 H21),	 1.10	 (d,	 6H,	H26+H27),	 1.12	 (s,	 3H,	
H19),	1.135	(m,	1H,	H9),	1.139	(m,	2H,	H1B	),	1.18‐1.19	(m,	4H,	
H14+H15B+H17),	 1.201	 (m,	 2H,	 H24),	 1.205	 (m,	 2H,	 H22),	




6.735	 (d,	1H,	3’	Harom),	6.77	 (m,	1H,	4’	Harom),	7.22	 (d,	1H,	
6’Harom),	8.62,	(br.	s,	2H,	NH2).	13C	NMR	(100	MHZ,	DMSO‐d6,	
δ,	 ppm):	 12.2	 (Me‐18),	 19.2	 (Me‐21),	 19.6	 (Me‐19),	 21.3	 (C‐
11),	 23.0	 (C‐23),	 23.2	 (C‐27+C‐26),	 23.9	 (C‐16),	 24.4	 (C‐15),	
28.0	 (C‐14),	 28.1	 (C‐25),	 32.1	 (C‐2),	 32.11	 (C‐8),	 32.12	 (C‐7),	
37.5	 (C‐20),	 38.0	 (C‐22),	 39.5	 (C‐10),	 39.6	 (C‐9),	 40.1	 (C‐1),	
40.19	(C‐17),	40.25	(C‐12),	40.30	(C‐4),	40.60	(C‐3),	40.80	(	C‐
24),	 40.89	 (C‐13),	 110.2	 (C‐1’),	 116.0	 (C‐5’),	 118.0	 (3’‐CMe),	
120.4	(C‐6),	130.6	(C‐6’),	132.0	(C‐4’),	141.9	(C‐5),	151.6(C‐2’),	
165.0	 (CO2).	Anal.	 calcd.	 for	 C34H51NO2:	 C,	 80.74;	H,	 10.16;	N,	
2.77.	Found:	C,	80.46;	H,	9.95;	N,	2.49%.	
(10R,	13R)‐10,	13‐dimethyl‐17‐((R)‐6‐methylheptan‐2‐yl)‐2,	
3,	 4,	 7,	 8,	 9,	 10,	 11,	 12,	 13,	 14,	 15,	 16,	 17‐tetradecahydro‐1H‐
cyclopenta[a]phenanthren‐3‐yl	 2‐(1‐(4‐chlorobenzoyl)‐5‐met‐




N,	 hetero),	 1562	 (C=C,	 aliphatic	 and	 aromatic),	 1650	 (C=O,	
amid),	 1718	 (C=O,	 ester),	 3043	 (=CH,	 aliphatic),	 3059	 (C‐H,	
aromatic).	 1H	NMR	(400	MHz,	DMSO‐d6,	 δ,	ppm):	0.87	 (s,	3H,	
H18),	 1.10	 (d,	 3H,	H21),	 1.11‐1.12	 (d,	 6H,	H26 H27),	 1.14	 (s,	





3.57	 (s,	 3H,	 5’OMe),	 5.29	 (t,	 1H,	 H6),	 7.61‐7.625	 (m,	 7H,	
Harom).	13C	NMR	(100	MHZ,	DMSO‐d6,	δ,	ppm):	12.18	(Me‐18),	




(C‐1	 ),	 40.35	 (C‐9),	 40.40	 (C‐12),	 40.45	 (C‐4),	 40.50	 (5’OMe),	
40.58	 (C‐17),	 42.60	 (C‐24),	 42.70	 (C‐13),	 50.42	 (C‐3),	 113.29	
(C‐3’),	 120.70	 (C‐4’),	 128.0	 (C‐7’),	 129.04	 (C‐6’),	 130.0	 (C‐6),	
131.97‐131.99	 (C‐arom),	 132.31	 (C‐3a’),	 132.32	 (C‐5	 +	 C‐Cl),	









1100	 (C‐O,	 hetero),	 1254	 (C‐N,	 aliphatic),	 1300	 (C‐N,	
aromatic),	 1592	 (C=C,	 aliphatic	 and	 aromatic),	 1746	 (C=O,	
ester),	 3018	 (=C‐H,	 aliphatic),	 3040	 (C‐H,	 aromatic).	 1H	NMR	












MHZ,	 DMSO‐d6,	 δ,	 ppm):	 12.2	 (Me‐18),	 14.9	 (C‐16’+C‐19’+C‐
23’+C‐20’),	 19.2	 (Me‐21),	 19.6	 (Me‐19),	 21.3	 (C‐11),	 23.1	 (C‐
23),	 23.2	 (C‐26+C‐27),	 24.1	 (C‐16),	 24.3	 (C‐15),	 27.9	 (C‐14),	
28.0	(C‐25),	32.09	(C‐2),	32.15	(C‐8),	32.19	(C‐7),	37.7	(C‐20),	
39.5	(C‐22),	39.8	(C‐10),	40.0	(C‐1),	40.31	(C‐12),	40.38	(C‐4),	
40.8	 (C‐24),	 40.81	 (C‐13),	 40.9	 (C‐9),	 42.6	 (C‐9’),	 42.8	 (C‐
17’+C‐18	‘+C‐22’+C‐21’),	44.0	(C‐17),	54.0	(C‐3),	106.71	(C‐5’),	
106.72	(C‐4’),	119.1	(C‐7’),	119.2	(C‐2’	),	128.9	(C‐6),	129.0	(8‐
a’	 +	 9‐a’),	 129.4	 (C‐13’),	 130.3	 (C‐1’+C‐8’+C‐15’),	 130.7	 (C‐
11’+C‐12’),	130.8	(C‐14’),	141.0	(C‐5),	142.1	(C‐10’),	144.4	(C‐




3,	 4,	 7,	 8,	 9,	 10,	 11,	 12,	 13,	 14,	 15,	 16,	 17‐tetradecahydro‐1H‐
cyclopenta[a]phenanthren‐3‐yl	 3‐(2‐hydroxyphenyl)propanoate	
(6):	 From	 2‐hydroxy	 benzyl	 acetic	 acid	 (14),	 (0.4	 g).	 Color:	
Brown.	 Yield:	 92%.	 M.p:	 125‐127	 °C.	 FT‐IR	 (KBr,	 ν,	 cm‐1):	
1037‐1239	 (C‐O,	 ester),	 1350	 (C‐O,	 phenol),	 1539	 (C=C,	
aliphatic	 and	 aromatic),	 1740	 (C=O,	 ester),	 3029	 (=C‐H,	
aliphatic)),	3070	(C‐H,	aromatic),	3360	(O‐H,	phenol).	1H	NMR	




(m,	 2H,	 H2B),	 1.410	 (m,	 2H,	 H20+H8),	 1.415	 (m,	 2H,	 H12B),	
1.50	 (m,	 2H,	 H11B),	 1.51	 (m,	 2H,	 H7B)	 1.52	 (m,	 2H,	 H16B),	
1.54	 (m,	 1H,	H25),	 2.15	 (m,	2H,	H4),	4.059	 (m,	1H,	H3),	 4.35	
(m,	2H,	3”H),	4.37	(m,	2H,	4”H),	5.28	(t,	1H,	H6),	7.631‐7.639 
(m,	4H,	Harom),	8.00	(s,	1H,	OH).	13C	NMR	(100	MHZ,	DMSO‐d6,	




















Olefin),	 7.58‐7.60	 (m,	 5H,	 2”Harom	 +	 6”Harom	 +	 3”Harom	 +	
4”Harom	+	5”Harom).	 13C	NMR	 (100	MHZ,	DMSO‐d6,	 δ,	 ppm):	












C‐4),	 40.90	 (C‐9),	 42.70	 (C‐24),	 42.75	 (C‐17),	 42.79	 (C‐13),	
56.39	 (C‐3),	 129.1	 (C‐3’),	 129.2	 (C‐6),	 129.5‐130.0	 (C‐arom),	
133.18	 (C‐1’),	 140.0	 (C‐5),	 141.98	 (C‐4’),	 167.0	 (CO2H).	 Anal.	
calcd.	 for	 C36H52O2:	 C,	 83.67;	 H,	 10.14.	 Found:	 C,	 83.45;	 H,	
9.98%.	
(10R,	13R)‐10,	13‐dimethyl‐17‐((R)‐6‐methylheptan‐2‐yl)‐2,	
3,	 4,	 7,	 8,	 9,	 10,	 11,	 12,	 13,	 14,	 15,	 16,	 17‐tetradecahydro‐1H‐
cyclopenta[a]phenanthren‐3‐yl	 4‐aminobenzoate	 (8):	 From	 4‐
Amino	 benzoic	 acid	 (16),	 (0.34	 g).	 Color:	 Brown.	 Yield:	 89%.	
M.p.:	 138‐140	 °C.	 1H	NMR	(400	MHz,	DMSO‐d6,	 δ,	ppm):	0.69	
(s,	 3H,	H‐18),	 0.929	 (d,	 3H,	H‐21),	 0.97‐0.98	 (d,	 6H,	H‐26+H‐
27),	1.02	(s,	3H,	H‐19),	1.03	(m,	1H,	H‐9	),	1.12	(m,	2H,	H1B),	
1.15‐1.18	 (m,	 4H,	 H‐14+H‐15B+H‐17),	 1.19	 (m,	 4H,	 H‐22+H‐
24),	 1.35	 (m,	 2H,	H‐23),	 1.42	 (m,	 2H,	H‐2B),	 1.43	 (m,	 2H,	H‐
20+H‐8),	1.44	(2H,	H‐12B),	1.51	(m,	2H,	H‐11B),	1.52	(m,	2H,	
H‐7A),	1.535	(m,	2H,	H‐16B),	1.55	(m,	1H,	H‐25),	2.17	(m,	2H,	
H‐4),	 3.30	 (m,	 1H,	 H‐3),	 5.29	 (t,	 1H,	 H‐6),	 7.05	 (s,	 2H,	 NH2),	
7.64‐7.67	 (m,	 4H,	 2’H	 arom+3’H	 arom+5’H	 arom+6’H	 arom).	






5’),	 120.7	 (C‐1’),	 130.7	 (C‐2’+C‐6’),	 142.0	 (C‐5),	 154.0	 (C‐4’),	

















taking	 a	 small	 amount	 of	 the	 sample	 (1‐2	 mg)	 and	 placed	





Liquid	 crystal	 phases	 were	 characterized	 by	 using	 a	

















cholesterol	 with	 compounds	 9‐16,	 respectively,	 in	 the	
presence	 of	 pyridine,	 triphenylphosphine	 and	 diethylazo‐
dicarboxylate	as	catalysts	(Scheme	1).	
The	reaction	proceeds	via	nucleophileic	attack	of	the	Ph3P	
on	azo	group	 in	DEAD	and	nucleophilic	 attack	of	 carboxylate	
anion	on	 triphenylphosphonium	according	 to	SN2	mechanism	
[26].	
The	 structures	 of	 these	 compounds	 have	 been	 charac‐








antimicrobial	 activity	 invitro	 against	 bacteria	 (Staphylococcus	
aureues,	 Escherichia	 coli)	 and	 fungal	 (Candida	 albicans)	 as	
shown	 in	 Figure	 1.	 From	 the	 results	 given	 in	 Table	 1,	
compounds	 1	 and	 2	 showed	 slightly	 activity	 against	
Escherichia	 coli	 and	 Staphylococcus	 aureues	 while	 showed	
moderated	 activity	 against	 Candidia	 albicans.	 Compound	 3	
showed	 no	 activity	 against	 Escherichia	 coli	 while	 showed	
moderated	activity	against	Staphylococcus	aureus	and	Candidia	
albicans.	 Compound	 4	 and	 5	 showed	 moderated	 activity	
against	Escherichia	coli	and	Candidia	albicans	while	compound	
4	 showed	 very	 activity	 against	 Staphylococcus	 aureus.	
Compound	 5	 showed	 slightly	 activity	 against	 Staphylococcus	
aureus.	 Compound	 6	 showed	 moderated	 activity	 against	
Escherichia	 coli	 while	 showed	 high	 activity	 against	
Staphylococcus	 aureus	 and	 Candidia	 albicans.	 Compound	 7	
showed	no	activity	against	Escherichia	coli	while	showed	very	
activity	 against	 Staphylococcus	 aureus	 and	 Candidia	 albicans.	
Compound	 8	 showed	 moderated	 activity	 against	 Escherichia	







Candida	albicans Staphylococcus	aureues Escherichia	coli Derivatives	
++	 +	 +	 1 
++	 +	 +	 2 
++	 ++	 ‐ 3 
++	 +++	 ++	 4 
++	 +	 ++	 5 
++++	 ++++	 ++	 6 
+++	 +++	 ‐ 7 





























When	 melting	 the	 solid	 phase	 moves	 to	 the	 liquid	
crystalline	 phase.	 First,	 the	 shape	 will	 appear	 histological	
shape	 most	 systematic	 (Smectic	 phase),	 the	 continues	 of	
increase	 temperature	 gets	 quick	 change	 refers	 to	 move	 to	
another	phase	transitions	less	regularly	(Nematic	phase)	[27],	
then	moves	down	to	 the	 isotropic	 liquid	phase,	when	cooling	
the	 fluid	 isotropic	 will	 appear	 blue	 phase	 (Liquid	 crystal	








The	 derivatives	 1‐4	 showed	 four	 peaks,	 two	 peaks	 at	
heating	 and	 two	 peaks	 at	 cooling.	 At	 heating	 the	 first	 peak	
represent	thermal	transition	from	solid	phase	to	liquid	crystal	
phase;	 the	 second	 peak	 represents	 thermal	 transition	 from	
liquid	crystal	phase	to	isotropic	phase	[29].	At	cooling	the	first	














ΔT	/	°C	T	/	°CC→I	T	/°CM→I	 T	/°CC→M Derivatives	 
58	 ‐ 130	 72	 1 
14	 ‐ 112	 98	 2 
56	 ‐ 106	 80	 3 






ΔT	/	°C		T	/	°CI→CT	/	°CM→C 	T	/	°CI→M Derivatives 
‐38	 ‐79117 1 
‐20	 ‐	75 95 2 
‐20	 ‐	76 96 3 





ΔSK.J/mol.K	C→IΔSK.J/mol.K	M→I ΔSK.J/mol.K C→M ΔHK.J/mol	C→IΔHK.J/mol	M→I	 ΔHK.J/mol	C→M Derivatives	
‐	‐5×10‐7 ‐6×10‐7 ‐‐4×10‐5 ‐8×10‐5 1 
‐	‐1×10‐9 ‐3×10‐9 ‐‐2×10‐7 ‐3×10‐7 2 
‐	‐1×10‐7 ‐8×10‐7 ‐‐2×10‐5 ‐7×10‐5 3 





ΔSK.J/mol.K I→CΔSK.J/mol.K	M→C ΔSK.J/mol.K I→MΔHK.J/mol	I→CΔHK.J/mol	M→C ΔHK.J/mol	I→M Derivatives 
‐	3×10‐7 5×10‐7 ‐3×10‐5 7×10‐5 1 
‐	2×10‐9 4×10‐7 ‐2×10‐7 3×10‐5 2 
‐	3×10‐7 5×10‐7 ‐3×10‐5 4×10‐5 3 

















The	 cause	 of	 not	 appearance	 liquid	 crystal	 phase	 in	









∆GC‐M	=	∆HC‐M	–	TM.	∆SC‐M			 	 	 	 (1)	
	
∆GM‐I	=	∆HM‐I–	TI.	∆SM‐I		 	 	 	 (2)	
	
∆GC‐I	=	∆HC‐I–	TI.	∆SC‐I		 	 	 	 (3)	
	
At	cooling	
∆GC‐M	=	∆HC‐M	–	TM.	∆SC‐M			 	 	 	 (4)	
	
∆GM‐I	=	∆HM‐I–	TI.	∆SM‐I		 	 	 	 (5)	
	








911 1 919 9	
95 2 100 10	
906 3 918 11	
80 4 97 12	





The	 behavior	 of	 electrical	 conductivity	 of	 prepared	
derivatives	 solutions	were	measured	 by	 using	 (0.002M)	 as	 a	
concentration	in	the	experiment	and	the	data	were	illustrated	
in	Table	6.		
The	 results	 showed	 that	 the	 electrical	 conductivity	 of	
derivatives	(1‐5)	Less	than	electrical	conductivity	for	starting	
materials	 (9‐13),	 respectively,	 the	 reason	was	decreasing	 the	






A	 series	 of	 new	 ester	 derivatives	 of	 cholesterol	 has	 been	
described	by	applying	Mitsunobu	reaction.	All	the	compounds	
were	 achieved	 according	 to	 the	 data	 shown	 by	 the	 physical	
and	chemical	analysis	including	(TLC,	melting	point,	elemental	
analysis,	 FT‐IR	 spectroscopy,	 NMR	 spectroscopy,	 POM	
analysis,	 DSC	 analysis	 and	 electrical	 conductivity	 measure‐
ments.	All	the	derivatives	showed	inversion	in	configuration	at	
C‐3	 during	 the	 formation	 of	 β‐ester	 analogues.	Most	 of	 these	
compounds	 showed	 high	 microbial	 activity	 against	 some	
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